MedMira Inc

STU:47M (Canada)  
€ 0.06 (+3.6%) May 9
At Loss
Market Cap:
€ 42.81M ($ 46.12M)
Enterprise V:
€ 48.28M ($ 52.01M)
Volume:
-
Avg Vol (2M):
22.45K
Also Trade In:

Business Description

Description
MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.1
Equity-to-Asset -3.6
Debt-to-Equity -0.56
Debt-to-EBITDA -5.35
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -34.71
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EPS without NRI Growth Rate -10.1
3-Year Book Growth Rate 2.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 77.28
9-Day RSI 70.19
14-Day RSI 64.38
6-1 Month Momentum % -2.86
12-1 Month Momentum % -17.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.15
Quick Ratio 0.13
Cash Ratio 0.05
Days Inventory 434.28
Days Sales Outstanding 1178.2
Days Payable 7096.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.9
Shareholder Yield % -1.04

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 61.52
Operating Margin % -459.8
Net Margin % -716.67
FCF Margin % -491.04
ROA % -72.18
ROIC % -17.85
ROC (Joel Greenblatt) % -96.39

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 96.06
EV-to-EBIT -37.49
EV-to-EBITDA -42.4
EV-to-Revenue 173.55
EV-to-FCF -35.6
Earnings Yield (Greenblatt) % -2.66
FCF Yield % -3.19

Financials

STU:47M's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

MedMira Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.279
EPS (TTM) (€) -0.004
Beta 0
Volatility % 39.36
14-Day RSI 64.38
14-Day ATR (€) 0.003768
20-Day SMA (€) 0.04965
12-1 Month Momentum % -17.74
52-Week Range (€) 0.0425 - 0.0835
Shares Outstanding (Mil) 701.73

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

MedMira Inc Filings

Filing Date Document Date Form
No Filing Data

MedMira Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

MedMira Inc Frequently Asked Questions

What is MedMira Inc(STU:47M)'s stock price today?
The current price of STU:47M is €0.06. The 52 week high of STU:47M is €0.08 and 52 week low is €0.04.
When is next earnings date of MedMira Inc(STU:47M)?
The next earnings date of MedMira Inc(STU:47M) is .
Does MedMira Inc(STU:47M) pay dividends? If so, how much?
MedMira Inc(STU:47M) does not pay dividend.

Press Release

Subject Date
No Press Release